Consequently, contrary to their HPV-negative counterparts, HPV-positive OPSCC bear high p16 levels, and the overexpression of p16 is used in routine clinical practice as a surrogate marker of tumor HPV status [24]. The gene discussed is CDKN2A; the disease is neoplasm.